Roache JD, Pavlicova M, Campbell A, Choo TH, et al. Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcohol Clin Exp Res 2021;45:2569-2578.
PMID: 34698397